chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: first vaccination almost 2 months ago; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (first vaccination almost 2 months ago) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (first vaccination almost 2 months ago). At the time of the report, PRODUCT DOSE OMISSION ISSUE (first vaccination almost 2 months ago) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant drug was not reported. Treatment medication was not reported.  It was reported that patient had dose 1 two months ago.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Symptoms; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Symptoms) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In February 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Symptoms). At the time of the report, VACCINATION COMPLICATION (Symptoms) outcome was unknown.      No concomitant medications were reported. Treatment medications were not provided by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Erythema
Clinical narrative: Red spot on that arm getting bigger; This spontaneous case was reported by a patient and describes the occurrence of ERYTHEMA (Red spot on that arm getting bigger) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 2 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (Red spot on that arm getting bigger). At the time of the report, ERYTHEMA (Red spot on that arm getting bigger) outcome was unknown. Not Provided          NO Concomitant products used by the patient included. Treatment information was not provided Post vaccination patient experienced ret spot on the arm getting bigger.
Sex: U
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: batch of hives that showed up about two weeks after the first shot; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (batch of hives that showed up about two weeks after the first shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced URTICARIA (batch of hives that showed up about two weeks after the first shot). At the time of the report, URTICARIA (batch of hives that showed up about two weeks after the first shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were provided No treatment information provided.    This case was linked to MOD-2021-230169 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Malaise, Rash, Swelling
Clinical narrative: feel weird long not far from where the shot was given; swelling; arm is still pink in a big patch; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (feel weird long not far from where the shot was given), SWELLING (swelling), RASH (arm is still pink in a big patch) and FATIGUE (fatigue) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (feel weird long not far from where the shot was given), SWELLING (swelling), RASH (arm is still pink in a big patch) and FATIGUE (fatigue). At the time of the report, MALAISE (feel weird long not far from where the shot was given), SWELLING (swelling), RASH (arm is still pink in a big patch) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitants were reported. No treatment was reported.
Sex: U
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Batch of hives that similar but slightly different reaction; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Batch of hives that similar but slightly different reaction) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced URTICARIA (Batch of hives that similar but slightly different reaction). At the time of the report, URTICARIA (Batch of hives that similar but slightly different reaction) outcome was unknown.            No Concomitant Medications were provided by the reporter. The patient experienced the adverse event 3 to 4 weeks after the second shot. No Treatment medications were provided by the reporter.       Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Getting COVID After the Vaccine, Symptoms of covid after vaccination; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Getting COVID After the Vaccine, Symptoms of covid after vaccination) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Getting COVID After the Vaccine, Symptoms of covid after vaccination). At the time of the report, COVID-19 (Getting COVID After the Vaccine, Symptoms of covid after vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication and treatment were provided.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue, Tinnitus
Clinical narrative: Caller did no get the second dose 36 days after the first; his mild tinnitus that only bothered him in one ear now developed into moderate tinnitus in both of his ears.; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (his mild tinnitus that only bothered him in one ear now developed into moderate tinnitus in both of his ears.) and PRODUCT DOSE OMISSION ISSUE (Caller did no get the second dose 36 days after the first) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022B21A) for COVID-19 vaccination.     Concurrent medical conditions included Tinnitus since 2020.    On 13-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-May-2021, the patient experienced TINNITUS (his mild tinnitus that only bothered him in one ear now developed into moderate tinnitus in both of his ears.). On 19-Jun-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Caller did no get the second dose 36 days after the first). At the time of the report, TINNITUS (his mild tinnitus that only bothered him in one ear now developed into moderate tinnitus in both of his ears.) was resolving and PRODUCT DOSE OMISSION ISSUE (Caller did no get the second dose 36 days after the first) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date.       No Treatment medications were provided. No concomitant medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: updated action taken, updated event details and updated narrative On 12-Aug-2021: Fallow up received and contains no new information.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pollakiuria, Vaccination site erythema
Clinical narrative: Peeing a lot; Tremendous chills; Red mark at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of POLLAKIURIA (Peeing a lot), VACCINATION SITE ERYTHEMA (Red mark at the injection site) and CHILLS (Tremendous chills) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20A and 002A21A) for COVID-19 vaccination.     Concurrent medical conditions included Angina pectoris. Concomitant products included METOPROLOL for Angina pectoris.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (Red mark at the injection site). On an unknown date, the patient experienced POLLAKIURIA (Peeing a lot) and CHILLS (Tremendous chills). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. On 14-Feb-2021, VACCINATION SITE ERYTHEMA (Red mark at the injection site) had resolved. At the time of the report, POLLAKIURIA (Peeing a lot) and CHILLS (Tremendous chills) had resolved.            Treatment medication include Tylenol. Concomitant medications include statin and vitamins. patient stated she had taken in a lot of fluid as she was "peeing a lot".  Action taken with the drug in response to the events was not applicable.   This case was linked to MOD-2021-038242 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: Events- tremendous chills and peeing a lot updated. Event outcome for this two events recovered/resolved updated.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vertigo
Clinical narrative: Vertigo; Left arm at shot site turned pinkish for about 4 inch area with itching; Left arm at shot site turned tomato red and itched about  one week aftr first shot; This spontaneous case was reported by a patient and describes the occurrence of VERTIGO (Vertigo), VACCINATION SITE PRURITUS (Left arm at shot site turned pinkish for about 4 inch area with itching) and VACCINATION SITE ERYTHEMA (Left arm at shot site turned tomato red and itched about  one week aftr first shot) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 030A21A) for COVID-19 vaccination.     No medical history and laboratory data are provided by the reporter.  Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR), LISINOPRIL, ACETYLSALICYLIC ACID (ASPIRIN 81), FOLIC ACID and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Apr-2021, the patient experienced VACCINATION SITE PRURITUS (Left arm at shot site turned pinkish for about 4 inch area with itching) and VACCINATION SITE ERYTHEMA (Left arm at shot site turned tomato red and itched about  one week aftr first shot). On an unknown date, the patient experienced VERTIGO (Vertigo). At the time of the report, VERTIGO (Vertigo), VACCINATION SITE PRURITUS (Left arm at shot site turned pinkish for about 4 inch area with itching) and VACCINATION SITE ERYTHEMA (Left arm at shot site turned tomato red and itched about  one week aftr first shot) had resolved.            No treatment medications were reported.  No acute illnesses at the time of vaccination and up to one month before.   This case was linked to MOD-2021-059663 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Follow up received- on 15 JUL 2021: event outcome was updated.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Cough, Feeling hot, Hypersensitivity, Myalgia
Clinical narrative: Swollen arm; Feeling hot; Painful arm; Rash is less severe; Itching at injection site; Allergic reaction; Rhinitis; myalgia; arthralgia; Fever; Redness; Cough; Edema; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen arm), FEELING HOT (Feeling hot), PAIN IN EXTREMITY (Painful arm), COUGH (Cough) and OEDEMA (Edema) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for an unreported indication: SPIRONOLACTONE since 2003, CRESTOR since 2012, CO Q-10 since 2012, SINGULAIR since 2019, VIT D [COLECALCIFEROL] since 2019 and ALLEGRA (2o+ years) since an unknown date. Concurrent medical conditions included Drug allergy (omnicef,chlorhexidine) and Asthma. Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR) for Cholesterol levels raised, FEXOFENADINE HYDROCHLORIDE (ALLEGRA) and MONTELUKAST SODIUM (SINGULAIR) for Seasonal allergy, COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) for Vitamin D deficiency, SPIRONOLACTONE for an unknown indication.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced COUGH (Cough), OEDEMA (Edema), RHINITIS (Rhinitis), MYALGIA (myalgia), ARTHRALGIA (arthralgia), PYREXIA (Fever) and VACCINATION SITE ERYTHEMA (Redness). On an unknown date, the patient experienced PERIPHERAL SWELLING (Swollen arm), FEELING HOT (Feeling hot), PAIN IN EXTREMITY (Painful arm), HYPERSENSITIVITY (Allergic reaction), RASH (Rash is less severe) and VACCINATION SITE PRURITUS (Itching at injection site). The patient was treated with PARACETAMOL (TYLENOL) on 24-Feb-2021 for Fever, at a dose of 1 dosage form and PREDNISONE ongoing since an unknown date at a dose of 20 milligram. On 08-Mar-2021, COUGH (Cough), OEDEMA (Edema), RHINITIS (Rhinitis), PYREXIA (Fever) and VACCINATION SITE ERYTHEMA (Redness) had resolved. At the time of the report, PERIPHERAL SWELLING (Swollen arm), FEELING HOT (Feeling hot), PAIN IN EXTREMITY (Painful arm), HYPERSENSITIVITY (Allergic reaction), RASH (Rash is less severe) and VACCINATION SITE PRURITUS (Itching at injection site) outcome was unknown and MYALGIA (myalgia) and ARTHRALGIA (arthralgia) had resolved.            For asthma patient using breo inhaler and albuterol inhaler. Patient took CO Q 10 200 g  orally once daily from 02/2012 used for statin as concomitant.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Oedema, Pain in extremity, Peripheral swelling, Pyrexia, Rash
Clinical narrative: Swollen arm; Feeling hot; Painful arm; Rash is less severe; Itching at injection site; Allergic reaction; Rhinitis; myalgia; arthralgia; Fever; Redness; Cough; Edema; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen arm), FEELING HOT (Feeling hot), PAIN IN EXTREMITY (Painful arm), COUGH (Cough) and OEDEMA (Edema) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for an unreported indication: SPIRONOLACTONE since 2003, CRESTOR since 2012, CO Q-10 since 2012, SINGULAIR since 2019, VIT D [COLECALCIFEROL] since 2019 and ALLEGRA (2o+ years) since an unknown date. Concurrent medical conditions included Drug allergy (omnicef,chlorhexidine) and Asthma. Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR) for Cholesterol levels raised, FEXOFENADINE HYDROCHLORIDE (ALLEGRA) and MONTELUKAST SODIUM (SINGULAIR) for Seasonal allergy, COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) for Vitamin D deficiency, SPIRONOLACTONE for an unknown indication.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced COUGH (Cough), OEDEMA (Edema), RHINITIS (Rhinitis), MYALGIA (myalgia), ARTHRALGIA (arthralgia), PYREXIA (Fever) and VACCINATION SITE ERYTHEMA (Redness). On an unknown date, the patient experienced PERIPHERAL SWELLING (Swollen arm), FEELING HOT (Feeling hot), PAIN IN EXTREMITY (Painful arm), HYPERSENSITIVITY (Allergic reaction), RASH (Rash is less severe) and VACCINATION SITE PRURITUS (Itching at injection site). The patient was treated with PARACETAMOL (TYLENOL) on 24-Feb-2021 for Fever, at a dose of 1 dosage form and PREDNISONE ongoing since an unknown date at a dose of 20 milligram. On 08-Mar-2021, COUGH (Cough), OEDEMA (Edema), RHINITIS (Rhinitis), PYREXIA (Fever) and VACCINATION SITE ERYTHEMA (Redness) had resolved. At the time of the report, PERIPHERAL SWELLING (Swollen arm), FEELING HOT (Feeling hot), PAIN IN EXTREMITY (Painful arm), HYPERSENSITIVITY (Allergic reaction), RASH (Rash is less severe) and VACCINATION SITE PRURITUS (Itching at injection site) outcome was unknown and MYALGIA (myalgia) and ARTHRALGIA (arthralgia) had resolved.            For asthma patient using breo inhaler and albuterol inhaler. Patient took CO Q 10 200 g  orally once daily from 02/2012 used for statin as concomitant.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinitis, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: Swollen arm; Feeling hot; Painful arm; Rash is less severe; Itching at injection site; Allergic reaction; Rhinitis; myalgia; arthralgia; Fever; Redness; Cough; Edema; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen arm), FEELING HOT (Feeling hot), PAIN IN EXTREMITY (Painful arm), COUGH (Cough) and OEDEMA (Edema) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for an unreported indication: SPIRONOLACTONE since 2003, CRESTOR since 2012, CO Q-10 since 2012, SINGULAIR since 2019, VIT D [COLECALCIFEROL] since 2019 and ALLEGRA (2o+ years) since an unknown date. Concurrent medical conditions included Drug allergy (omnicef,chlorhexidine) and Asthma. Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR) for Cholesterol levels raised, FEXOFENADINE HYDROCHLORIDE (ALLEGRA) and MONTELUKAST SODIUM (SINGULAIR) for Seasonal allergy, COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) for Vitamin D deficiency, SPIRONOLACTONE for an unknown indication.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced COUGH (Cough), OEDEMA (Edema), RHINITIS (Rhinitis), MYALGIA (myalgia), ARTHRALGIA (arthralgia), PYREXIA (Fever) and VACCINATION SITE ERYTHEMA (Redness). On an unknown date, the patient experienced PERIPHERAL SWELLING (Swollen arm), FEELING HOT (Feeling hot), PAIN IN EXTREMITY (Painful arm), HYPERSENSITIVITY (Allergic reaction), RASH (Rash is less severe) and VACCINATION SITE PRURITUS (Itching at injection site). The patient was treated with PARACETAMOL (TYLENOL) on 24-Feb-2021 for Fever, at a dose of 1 dosage form and PREDNISONE ongoing since an unknown date at a dose of 20 milligram. On 08-Mar-2021, COUGH (Cough), OEDEMA (Edema), RHINITIS (Rhinitis), PYREXIA (Fever) and VACCINATION SITE ERYTHEMA (Redness) had resolved. At the time of the report, PERIPHERAL SWELLING (Swollen arm), FEELING HOT (Feeling hot), PAIN IN EXTREMITY (Painful arm), HYPERSENSITIVITY (Allergic reaction), RASH (Rash is less severe) and VACCINATION SITE PRURITUS (Itching at injection site) outcome was unknown and MYALGIA (myalgia) and ARTHRALGIA (arthralgia) had resolved.            For asthma patient using breo inhaler and albuterol inhaler. Patient took CO Q 10 200 g  orally once daily from 02/2012 used for statin as concomitant.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Decreased appetite, Fatigue, Headache, Mood altered, SARS-CoV-2 test
Clinical narrative: Lost my appetite/doesn't eat as well as he use to; Everything went to crap; lot of tiredness; severe headaches; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Lost my appetite/doesn't eat as well as he use to), MOOD ALTERED (Everything went to crap), FATIGUE (lot of tiredness) and HEADACHE (severe headaches) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No medical history was provided by reporter.  Concomitant products included METOPROLOL and AMLODIPINE for Blood pressure management.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced DECREASED APPETITE (Lost my appetite/doesn't eat as well as he use to). 01-Apr-2021, the patient experienced MOOD ALTERED (Everything went to crap), FATIGUE (lot of tiredness) and HEADACHE (severe headaches). At the time of the report, DECREASED APPETITE (Lost my appetite/doesn't eat as well as he use to), MOOD ALTERED (Everything went to crap), FATIGUE (lot of tiredness) and HEADACHE (severe headaches) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications were not provided.   This case was linked to MOD-2021-230194, MOD-2021-230194 (Patient Link).
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Fatigue
Clinical narrative: tired of being tired; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (tired of being tired) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 009C21A and 038A21A) for COVID-19 vaccination.     Concomitant products included METOPROLOL and AMLODIPINE for Blood pressure.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (tired of being tired). At the time of the report, FATIGUE (tired of being tired) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19: negative (Negative) Negative.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   It was reported that patient had the reactions still persisted after the 2nd dose. He said that they didn't get any worse and stayed about the same. No treatment medications were reported.   This case was linked to MOD-2021-230189 (Patient Link).
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Rash, Rash macular, Rash papular
Clinical narrative: Nephropathy in lower right foot; red/blotchy area; Looks like "mosquito bite"; Raised area; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Nephropathy in lower right foot), RASH MACULAR (red/blotchy area), RASH PAPULAR (Looks like "mosquito bite") and RASH (Raised area) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0S4C21A and 004C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Jun-2021, the patient experienced HYPOAESTHESIA (Nephropathy in lower right foot), RASH MACULAR (red/blotchy area), RASH PAPULAR (Looks like "mosquito bite") and RASH (Raised area). At the time of the report, HYPOAESTHESIA (Nephropathy in lower right foot), RASH MACULAR (red/blotchy area), RASH PAPULAR (Looks like "mosquito bite") and RASH (Raised area) had not resolved. Not Provided          No concomitant medication were given.  No treatment details were provided
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: I have some kind efdecrs /I have more sintoms about 2 dosis of moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (I have some kind efdecrs /I have more sintoms about 2 dosis of moderna vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (I have some kind efdecrs /I have more sintoms about 2 dosis of moderna vaccine). At the time of the report, VACCINATION COMPLICATION (I have some kind efdecrs /I have more sintoms about 2 dosis of moderna vaccine) outcome was unknown. Not Provided          Action taken with mRNA-1273 in response to the events was not applicable. No treatment medications were provided. No concomitant medications information was reported.   This case was linked to MOD-2021-230040 (Patient Link).   Reporter did not allow further contact
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Vaccination site rash
Clinical narrative: Arm swelling; Vaccination site rash; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Arm swelling) and VACCINATION SITE RASH (Vaccination site rash) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 01021A and 01M20A) for COVID-19 vaccination.     The patient's past medical history included Breast cancer in June 2006 and Mastectomy bilateral. Concurrent medical conditions included Lymphedema (Patient took Chiropractic therapy for 9 months and after that her arms returned to normal size.), Drug allergy (prednisone), Drug allergy (Tetracycline), Drug allergy, Drug allergy (Lisinopril), Drug allergy, Drug allergy (Beta blocker), Drug allergy (Hydrochlorothiazide), Drug allergy (Erythromycin), Drug allergy (Phenergen), Allergy to animals (\), Allergy to animals, Allergy to molds, Allergy to wool, Grass allergy, Cockroach allergy and Dust allergy. Concomitant products included COLECALCIFEROL (VIT D3) for Vitamin D low.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Feb-2021, the patient experienced VACCINATION SITE RASH (Vaccination site rash). On 01-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PERIPHERAL SWELLING (Arm swelling). At the time of the report, PERIPHERAL SWELLING (Arm swelling) and VACCINATION SITE RASH (Vaccination site rash) had not resolved.            This case was linked to MOD-2021-046652 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: Follow-up information received on23-JUN-2021 contains non-significant information..
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: lymph node in the right arm that has been swollen; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (lymph node in the right arm that has been swollen) in a 24-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (lymph node in the right arm that has been swollen). At the time of the report, LYMPHADENOPATHY (lymph node in the right arm that has been swollen) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.         Concomitant medication not provided.  Treatment information not provided.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Decreased appetite, Fatigue, SARS-CoV-2 test
Clinical narrative: weak; no appetite; tired; This spontaneous case was reported by an other health care professional and describes the occurrence of ASTHENIA (weak), DECREASED APPETITE (no appetite) and FATIGUE (tired) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. #045A21A) for COVID-19 vaccination.     Concomitant products included FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]) for an unknown indication.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced ASTHENIA (weak), DECREASED APPETITE (no appetite) and FATIGUE (tired). At the time of the report, ASTHENIA (weak), DECREASED APPETITE (no appetite) and FATIGUE (tired) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Mar-2021, SARS-CoV-2 test: negative (Negative) Lumiradx SARS-CoV-2 AG Test, nasal swab.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications include sinus and allergy unspecified medication and an unspecified cough medication.  No treatment medications were  provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Pain
Clinical narrative: pain; red area where she had the shot; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 22-Jun-2021 and was forwarded to Moderna on 22-Jun-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN (pain) and INJECTION SITE ERYTHEMA (red area where she had the shot) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included LATANOPROST for an unknown indication.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1. On an unknown date, the patient experienced PAIN (pain) and INJECTION SITE ERYTHEMA (red area where she had the shot). At the time of the report, PAIN (pain) and INJECTION SITE ERYTHEMA (red area where she had the shot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Abdominal discomfort, Diarrhoea, Vomiting
Clinical narrative: Diarrhea and my purps smell terrible; Stomach issues; Vomited; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea and my purps smell terrible), ABDOMINAL DISCOMFORT (Stomach issues) and VOMITING (Vomited) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In June 2020, the patient experienced DIARRHOEA (Diarrhea and my purps smell terrible), ABDOMINAL DISCOMFORT (Stomach issues) and VOMITING (Vomited). At the time of the report, DIARRHOEA (Diarrhea and my purps smell terrible), ABDOMINAL DISCOMFORT (Stomach issues) and VOMITING (Vomited) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product information was not provided. Treatment information was not provided
Sex: U
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: soreness in his arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (soreness in his arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027c21a) for COVID-19 vaccination.     No Medical History information was reported.    On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-May-2021, the patient experienced MYALGIA (soreness in his arm). At the time of the report, MYALGIA (soreness in his arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No  Concomitant medications were provided. No treatment was reported.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Vaccination site pain
Clinical narrative: application site pain; HEAD PAIN; JOINT PAIN; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (application site pain), HEADACHE (HEAD PAIN) and ARTHRALGIA (JOINT PAIN) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (application site pain), HEADACHE (HEAD PAIN) and ARTHRALGIA (JOINT PAIN). At the time of the report, VACCINATION SITE PAIN (application site pain), HEADACHE (HEAD PAIN) and ARTHRALGIA (JOINT PAIN) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided. Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity, Wrong product administered
Clinical narrative: sore arm; made a mistake giving the first vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and WRONG PRODUCT ADMINISTERED (made a mistake giving the first vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm) and WRONG PRODUCT ADMINISTERED (made a mistake giving the first vaccine). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (sore arm) and WRONG PRODUCT ADMINISTERED (made a mistake giving the first vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter said patient received Moderna first dose by mistake instead of Pfizer, and want to find out if it's ok to take second dose Pfizer vaccine instead of Moderna. No concomitant medications provided.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Paraesthesia, Vaccination complication
Clinical narrative: I'd like to report an adverse reaction; pain down my right arm; tingling in my left hand; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (I'd like to report an adverse reaction), PAIN IN EXTREMITY (pain down my right arm) and PARAESTHESIA (tingling in my left hand) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to nuts (allergies to tree nuts), Fruit allergy (allergies to birch fruit), Vegetable allergy (allergies to vegetables), Depression and Anxiety. Concomitant products included LORAZEPAM for Anxiety, SERTRALINE for Depression.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, the patient experienced PAIN IN EXTREMITY (pain down my right arm) and PARAESTHESIA (tingling in my left hand). On an unknown date, the patient experienced VACCINATION COMPLICATION (I'd like to report an adverse reaction). At the time of the report, VACCINATION COMPLICATION (I'd like to report an adverse reaction), PAIN IN EXTREMITY (pain down my right arm) and PARAESTHESIA (tingling in my left hand) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were reported.   This case was linked to MOD-2021-281440 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 09-Aug-2021: Followup received: Added reporter information .patient details, relevant history, concomitant medication, dose details of dose 1. new events.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Shoulder pain; This spontaneous case was reported by a non-health professional and describes the occurrence of ARTHRALGIA (Shoulder pain) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Jan-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced ARTHRALGIA (Shoulder pain). At the time of the report, ARTHRALGIA (Shoulder pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided. No treatment medication was provided by reporter. Patient had not used anything to alleviate the symptoms. Patient did not contacted patient's healthcare provider.   This case was linked to MOD-2021-020967 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: took longer to feel alright after this dose; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (took longer to feel alright after this dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Mar-2021, the patient experienced ILLNESS (took longer to feel alright after this dose). At the time of the report, ILLNESS (took longer to feel alright after this dose) had resolved.            Treatment medications include blood thinners. No concomitant medications was reported by the reporter. Action taken with mRNA-1273 in response to the events was not applicable   This case was linked to MOD-2021-042834 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Influenza like illness, Joint stiffness, Myalgia
Clinical narrative: All joints were locked up; Felt like I had the flu; Very weak; Hurt all over; Tired; This spontaneous case was reported by a consumer and describes the occurrence of JOINT STIFFNESS (All joints were locked up), INFLUENZA LIKE ILLNESS (Felt like I had the flu), ASTHENIA (Very weak), MYALGIA (Hurt all over) and FATIGUE (Tired) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced JOINT STIFFNESS (All joints were locked up), INFLUENZA LIKE ILLNESS (Felt like I had the flu), ASTHENIA (Very weak), MYALGIA (Hurt all over) and FATIGUE (Tired). At the time of the report, JOINT STIFFNESS (All joints were locked up), INFLUENZA LIKE ILLNESS (Felt like I had the flu), ASTHENIA (Very weak), MYALGIA (Hurt all over) and FATIGUE (Tired) outcome was unknown.            Concomitant medications were not provided Treatment medications were not provided by reporter   This case was linked to MOD-2021-040762 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of nausea (her son received the Moderna COVID-19 vaccine and felt a little queasy) in a male patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received a dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced nausea (her son received the Moderna COVID-19 vaccine and felt a little queasy). At the time of the report, nausea (her son received the Moderna COVID-19 vaccine and felt a little queasy) outcome: unknown/not provided. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. Concomitant medication and treatment information not provided.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Pyrexia
Clinical narrative: Developed upper back pain/ Probably muscular in origin; Fever; This spontaneous case was reported by a physician and describes the occurrence of BACK PAIN (Developed upper back pain/ Probably muscular in origin) and PYREXIA (Fever) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.    The patient's past medical history included Rheumatoid arthritis (moderate to severe ) since an unknown date.   On 08-Apr-2021, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. In 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Jun-2021, the patient experienced PYREXIA (Fever). On 16-Jun-2021, the patient experienced BACK PAIN (Developed upper back pain/ Probably muscular in origin). On 05-Jun-2021, PYREXIA (Fever) had resolved. At the time of the report, BACK PAIN (Developed upper back pain/ Probably muscular in origin) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were provided.  The reporter's causality for the events of fever and Developed upper back pain/ Probably muscular in origin with HUMIRA(adalimumab)) was no reasonable possibility.  No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pyrexia
Clinical narrative: fever; chills; muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), CHILLS (chills) and MYALGIA (muscle aches) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever), CHILLS (chills) and MYALGIA (muscle aches). At the time of the report, PYREXIA (fever), CHILLS (chills) and MYALGIA (muscle aches) outcome was unknown.            No treatment was reported. No concomitant medication was reported.
Sex: U
Vaccine: COVID19
Symptoms: Asthenia, Headache, Myalgia
Clinical narrative: weakness; severe headaches; body aches; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weakness), HEADACHE (severe headaches) and MYALGIA (body aches) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Jun-2021, the patient experienced ASTHENIA (weakness), HEADACHE (severe headaches) and MYALGIA (body aches). At the time of the report, ASTHENIA (weakness), HEADACHE (severe headaches) and MYALGIA (body aches) outcome was unknown.            Concomitant medication were not reported .  Treatment medication were not reported .
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pain, Pain in extremity, Pyrexia
Clinical narrative: Arm was sore; Body pain; chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was sore), PAIN (Body pain) and CHILLS (chills) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm was sore), PAIN (Body pain) and CHILLS (chills). At the time of the report, PAIN IN EXTREMITY (Arm was sore), PAIN (Body pain) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Mar-2021, Pyrexia: 98.2 f (abnormal) 98.2 F.         No concomitant medication reported. No treatment information reported. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable.   This case was linked to MOD-2021-035348 (Patient Link).